Exhibitors
ACannabis 2022 will feature a virtual Exhibit Hall where you can pop in and chat LIVE with our wonderful exhibitors, view their materials and find out more about what they do.
Entry to the virtual Exhibit Hall is included in your delegate registration, and the Exhibit Hall is open LIVE during the two days of the conference from 8am to 5pm (AEDT). The exhibitors look forward to welcoming you at their stand.
Please find below a list of our participating exhibitors.
Not Ranked
Cann Group
Cann Group Limited
Drawing on nearly three decades experience at global agribusiness Nufarm (ASX: NUF), and as the founding Chairman of MCIA, Cann Group's CEO Peter Crock is shaping the future of the medicinal cannabis industry in Australia. With Peter at the helm and working closely with an experienced board of directors, Cann Group (ASX: CAN) received the first commercial cultivation license in Australia, and was the first medicinal cannabis company to successfully list via an Initial Public Offering (IPO) on the Australian Securities Exchange (ASX), raising AUD$13.5 million.
To accelerate its growth, Cann Group has completed subsequent capital raisings totalling more than AUD$125m, which has enabled the advancement of its' most ambitious project to date; a controlled environment, automated production facility which will be capable of producing up to 70,000kg of medicinal cannabis products per year when at full capacity. This state-of-the-art facility in Mildura, Victoria is expected to be commissioned in early 2022.
With deep knowledge and experience in the areas of marketing, business and technology development, as well as mergers and acquisitions, Peter has overseen the growth and advancement of Cann Group.
In chairing the MCIA, Australia's peak industry body for medicinal cannabis, Peter is well versed in the management of regulatory framework in both Australia, and abroad.
To accelerate its growth, Cann Group has completed subsequent capital raisings totalling more than AUD$125m, which has enabled the advancement of its' most ambitious project to date; a controlled environment, automated production facility which will be capable of producing up to 70,000kg of medicinal cannabis products per year when at full capacity. This state-of-the-art facility in Mildura, Victoria is expected to be commissioned in early 2022.
With deep knowledge and experience in the areas of marketing, business and technology development, as well as mergers and acquisitions, Peter has overseen the growth and advancement of Cann Group.
In chairing the MCIA, Australia's peak industry body for medicinal cannabis, Peter is well versed in the management of regulatory framework in both Australia, and abroad.
Cannatrek
Cannatrek
Cannatrek is a technology-driven Australian company specialising in the research, cultivation, manufacturing, and delivery of medical cannabis.
Backed by medicinal licenses, we manage the entire supply chain of plant-based products. Our ecosystem of suppliers, doctors, pharmacists, and patients is connected by a cutting-edge digital platform delivering information on plant-based therapies to eligible patients.
Backed by medicinal licenses, we manage the entire supply chain of plant-based products. Our ecosystem of suppliers, doctors, pharmacists, and patients is connected by a cutting-edge digital platform delivering information on plant-based therapies to eligible patients.
CanGuide
CanGuide
CanGuide is an information, support and education service to assist consumers and health care professionals navigate the barriers to accessing and prescribing medical cannabis. It is a trusted service that is independent from industry and will provide evidence based medical cannabis information directly to 90% of Australian GPs. Partnership opportunities now available.
1300374537
HealthOne
HealthOne
HealthOne has over 20 years of experience driving access, sales and growth for healthcare brands. We encompass sales representation, education, brand strategy, marketing services and analytics and to maximise sales and market share optimisation. We partner with you to ensure you have the correct solution in place to take your brand to new heights. Visit our website to find out more. https://www.healthone.com.au/
LeafCann Group
LeafCann Group
LeafCann Group is an Australian-based, federally licensed botanical extracts company with a strong and innovative pipeline of GMP manufactured consumer and prescription products in new categories.
A world-class management team and leading international professionals on their advisory board bring decades of combined experience working with and in regulated Medical Cannabis Schemes, pharmaceutical and botanical extracts development, and consumer sales. LeafCann’s promise is to provide the highest quality, consistent product, at affordable prices, creating great value for patients and reliable dosing for physicians.
MCIA
MCIA
Medicinal Cannabis Industry Australia (MCIA) is the peak industry organisation for Australia’s licensed medicinal cannabis industry. It represents the mutual interests of members and other stakeholders to build a professional industry based on legitimacy, credibility and recognition for the Australian sector in domestic and international arenas. It acts as the voice for the licensed medicinal cannabis sector.
MCIA focus is about building an industry that enhances wellbeing through facilitating access to quality Australian medicinal cannabis products for Australian and global patients. The Australian industry and its products are built on sound science and underpinned by industry processes and standards that ensure patients, the medical community and governments have confidence in the sector and its products, services and information. MCIA provides stewardship to ensure the industry develops in a economic and sustainable manner, enabling access for patients in Australia and globally to quality Australian products.
MCIA aims to foster a sustainable and responsible industry that is trusted and valued for its social and economic contribution. This encompasses all activities of medicinal cannabis licence holders across research, cultivation and manufacturing and interaction with patients, the medical profession and communities.
MCIA focus is about building an industry that enhances wellbeing through facilitating access to quality Australian medicinal cannabis products for Australian and global patients. The Australian industry and its products are built on sound science and underpinned by industry processes and standards that ensure patients, the medical community and governments have confidence in the sector and its products, services and information. MCIA provides stewardship to ensure the industry develops in a economic and sustainable manner, enabling access for patients in Australia and globally to quality Australian products.
MCIA aims to foster a sustainable and responsible industry that is trusted and valued for its social and economic contribution. This encompasses all activities of medicinal cannabis licence holders across research, cultivation and manufacturing and interaction with patients, the medical profession and communities.
MedReleaf Australia
MedReleaf Australia
MedReleaf Australia is a Queensland-based medical cannabis company established in 2016. We exclusively distribute GMP certified medicinal cannabis products from our strategic partner Aurora Cannabis, including Dried, Softgel , cartridges and Oil formulations as well as manufacture our own range of locally producted products.
We dedicate ourselves to innovation and operational excellence in support of medical practitioners as they undertake their journey with this new and innovative therapy for their patients.
MedReleaf Australia is planning the construction of its state-of-art Australian facility and until then continues to import three key brands, MedReleaf, Aurora and CanniMed products for the Australian medical market. This is the widest range of medical cannabis products in Australia and includes heavily subsidised products as part of the rapidly growing MedReleaf Concession Scheme designed to make access more affordable for disadvantaged patients.
We dedicate ourselves to innovation and operational excellence in support of medical practitioners as they undertake their journey with this new and innovative therapy for their patients.
MedReleaf Australia is planning the construction of its state-of-art Australian facility and until then continues to import three key brands, MedReleaf, Aurora and CanniMed products for the Australian medical market. This is the widest range of medical cannabis products in Australia and includes heavily subsidised products as part of the rapidly growing MedReleaf Concession Scheme designed to make access more affordable for disadvantaged patients.
Nsw Department Of Primary Industries
NSW DPI
NSW DPI’s research history extends for more than 100 years and our high impact research solves key issues that impede the growth of our primary industries. Our suite of research programs is diverse and our scientific capability, rigour and understanding of the unique constraints faced by our industries is highly regarded, both nationally and internationally.
Scitek Australia Pty Ltd
Scitek
Scitek has 30 years pharmaceutical industry experience in providing high-end technologies for natural product processing and has been active in cannabis since legalisation. We are exclusive Premium Distributors for globally leading cannabis brands including Devex, Precision Extraction, MRXxtractors, Cascade, Asahi, Heidolph and Vacuubrand. Scitek’s focus is on providing honest cannabis production technology consulting, efficient ANZ standard compliant equipment supply and benchmark service.
Solve Scientific Pty Ltd
Solve Scientific
Solve Scientific and Gilson – The right choice for Cannabis Purification.
Gilson’s scalable CPC systems purify CBD from crude extracts of Cannabis. Adapt purification parameters according to which cannabinoids you target or the desired purity level to achieve THC-free extracts, pure cannabinoids, pharmaceutical-grade products, or standard molecules for reference materials or clinical evaluation. Leverage Gilson’s global expertise and Solve Scientific’s local (AU&NZ) experience, service, and support to accelerate your cannabis purification project outcomes.
Steritech
Steritech
Steritech is an Australian, family-owned company and are the partner of choice for sterilisation and irradiation within Australia’s Healthcare industry.
Our Victorian and Queensland sites are both approved to treat medicinal cannabis products, and we understand the regulatory standards and requirements needed for the industry. Irradiation is a safe, fast and effective treatment, and we look forward to working with Australia’s Medicinal Cannabis industry into the future.
Our Victorian and Queensland sites are both approved to treat medicinal cannabis products, and we understand the regulatory standards and requirements needed for the industry. Irradiation is a safe, fast and effective treatment, and we look forward to working with Australia’s Medicinal Cannabis industry into the future.